AMBER GILLARD: Open Payments
NPI 1174171946 · AURORA, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$458 in 21 payments from 11 companies in 2025. Trend: 2023 $836 · 2024 $422 · 2025 $458
Food & beverage: $458
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $107 |
| AstraZeneca Pharmaceuticals LP | 5 | $83 |
| ViiV Healthcare Company | 1 | $61 |
| Amgen Inc. | 2 | $46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $42 |
| PFIZER INC. | 2 | $33 |
| Madrigal Pharmaceuticals | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Lilly USA, LLC | 1 | $17 |
| Novo Nordisk Inc | 1 | $16 |
Products named: QULIPTA, DOVATO, JARDIANCE, BREZTRI, ELIQUIS, BOTOX, KRYSTEXXA, EVENITY.
Industry payments across CO — which companies pay providers there.
